Search results
The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, [1] [2] [3] and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the ...
The COVID-19 pandemic, also known as the coronavirus pandemic, is a global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in an outbreak in Wuhan , the capital of Hubei , China, in December 2019, before it spread to other areas of Asia ...
- 6,956,160 (reported), 17.5–31.4 million (estimated)
- Worldwide
- Coronavirus disease 2019 (COVID-19)
- Severe acute respiratory syndromecoronavirus 2 (SARS‑CoV‑2)
- Table 2a. Therapeutic Management of Nonhospitalized Adults With Mild to Moderate COVID-19 Who Do Not Require Supplemental Oxygen
- Table 2b. Therapeutic Management of Hospitalized Adults With COVID-19
All Patients
CLOSE
•Symptom management should be initiated for all patients (AIII).
•The Panel recommends against the use of dexamethasonea or other systemic corticosteroids in the absence of another indication (AIIb).
•There is currently a lack of safety and efficacy data on the use of dexamethasone in outpatients with COVID-19. Using systemic glucocorticoids in outpatients with COVID-19 may cause harm.
Patients Who Are at High Risk of Progressing to Severe COVID-19b,c
Hospitalized for Reasons Other Than COVID-19
OPEN
Clinical Scenario\tAntiviral or Immunomodulator Recommendation\tAnticoagulant Therapy Recommendation
Patients with mild to moderate COVID-19 who are at high risk of progressing to severe COVID-19a,b\tSee Therapeutic Management of Nonhospitalized Adults With COVID-19.\tFor patients without an indication for therapeutic anticoagulation:
•••••Prophylactic dose of heparin, unless contraindicated (AI); (BIII) for pregnant patients
•For a list of risk factors, see the CDC webpage Underlying Medical Conditions Associated With Higher Risk for Severe COVID-19.
Apr 17, 2021 · Abstract. COVID-19, a highly transmissible pandemic disease, is affecting millions of lives around the world. Severely infected patients show acute respiratory distress symptoms. Sustainable management strategies are required to save lives of the infected people and further preventing spread of the virus.
- Alamgir Kabir, Rajib Ahmed, Rasheduzzaman Chowdhury, Sheikh Muhammad Asher Iqbal, Ramasamy Paulmurug...
- 10.1016/j.micinf.2021.104832
- 2021
- May-June 2021
Jun 23, 2022 · The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Jun 16, 2021 · All COVID-19 suspected patients who are hospitalised should be isolated, and personal protective equipment should always be used by health care staff when in contact with the patients. 14 In order to take into account, the heterogenic nature of clinical presentations, patients with only general symptoms of infection are handled similarly to pati...
May 31, 2023 · Infectious disease topics. COVID-19. Facts. Case management and treatment. Facts. Case definition. Surveillance. The pathogen. Clinical features and sequelae. Epidemiology. Transmission. Case management and treatment. Public health control measures. Infection prevention and control in healthcare settings. Case management and treatment of COVID-19.